万维提示：
1、投稿方式：在线投稿。
2、官网网址：https://www.jvsvenous.org/
3、投稿网址：https://www.editorialmanager.com/jvsvl/default.aspx
4、期刊刊期：双月刊，逢单月出版。
2021年4月30星期五
投稿须知
【官网信息】
Instructions for Authors
Before submitting a manuscript to the Journal of Vascular Surgery Publications, you must review the instructions listed below. Submitted manuscripts will be considered for publication in either the Journal of Vascular Surgery, the Journal of Vascular Surgery:Venous and Lymphatic Disorders, or the Journal of Vascular Surgery Cases and Innovative Techniques. If your manuscript is selected for publication in the Journal of Vascular Surgery: Venous and Lymphatic Disorders you will be charged a fee for the color images included in your paper. The Publisher will collect this fee, which will be US $650.00 for the first color image and US $150.00 for each additional color image. Unless your figures are sufficiently complex to merit color, please submit charts and graphs in black and white. If your manuscript is accepted for the Journal of Vascular Surgery Cases and Innovative Techniques, you will be charged a US $550 publication fee.
Formatting Your Manuscript
Text formatting instructions. All text files must be prepared using: Microsoft Word, double spaced with Times New Roman 12-point font. Manuscripts must conform to standard English usage and are subject to editing in conformance with the policies of the Journals. Authors are encouraged to have their work professionally edited prior to submission and may use Elsevier Language Services for this purpose. Authors should consult the American Medical Association's Manual of Style (AMA Manual of Style: A Guide for Authors and Editors. Iverson C, Christiansen S, Flanagin A, et al. 10th ed. New York: Oxford University Press, 2007) (AMA-10).
Generic drug names from the United States Adopted Name (USAN) should be used. Proprietary drug names may be cited in parentheses. Generic equipment names should be used whenever possible, and the proprietary name of the equipment must be cited in parentheses after the proprietary name. Cite the manufacturer and the city, state, and country of manufacture. Measurements of height and weight, etc., should be stated in metric units. Hematologic and clinical chemistry measurements can be stated in System International (SI) units or non-SI units. Note that SI units are recommended in the "Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals" (http://www.icmje.org/icmje-recommendations.pdf). Only standard abbreviations should be used; avoid unusual or coined abbreviations. The first time any abbreviation is used it should be included in parentheses after the words it replaces. Abbreviations should not be used in the title or abstract.
Guidelines for Reporting on Vascular Surgery. Manuscripts should conform to the guidelines for reporting on vascular surgery. The following have been developed by the Document Oversight Committee and accepted by The Society for Vascular Surgery:
Venous severity scoring: An adjunct to venous outcome assessment. J Vasc Surg 2000;31:1307-12
Recommended standards for reports dealing with lower extremity ischemia: Revised version. J Vasc Surg 1997;26:517-38
Reporting standards in venous disease. J Vasc Surg 1988;8:172-81
Reporting standards in venous disease: an update. J Vasc Surg 1995;21:635-45
Suggested standards for reports dealing with cerebrovascular disease. J Vasc Surg 1988;8:721-9
Suggested standards for reporting on arterial aneurysms. J Vasc Surg 1991;13:452-8
Standards in noninvasive cerebrovascular testing. J Vasc Surg 1992;15:495-503
Reporting standards for lower extremity arterial endovascular procedures. J Vasc Surg 1993;17:1103-7
Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg 2002;35:603-10
Reporting standards for endovascular aortic aneurysm repair. J Vasc Surg. 2002;35:1048-60
Identifying and grading factors that modify the outcome of endovascular aortic aneurysm repair. J Vasc Surg. 2002;35:1061-6
Reporting standards of the Society for Vascular Surgery for thoracic outlet syndrome.J Vasc Surg 2016;3:23-35
Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease.J Vasc Surg 2016;64:227-8
Reporting standards for adverse events after medical device use in the peripheral vascular system.J Vasc Surg 2013;58:776-86
Reporting standards for carotid interventions from the Society for Vascular Surgery.J Vasc Surg 2011;53:1679-95
Reporting Standards. Authors must use the appropriate reporting guideline when writing any health research manuscript. Reporting Guidelines are available on the EQUATOR Network Web site, which also provides guidance on selecting a relevant guideline. Meeting these basic reporting standards will greatly improve the value of your manuscript and facilitate the peer review process. The following guidelines are endorsed by the Journal of Vascular Surgery Publications:
CONSORT: Randomized Controlled Trials
STROBE: Observational Studies
PRISMA: Meta-Analyses and Systematic Reviews
CARE: Case Reports
Visit the EQUATOR database or contact our editorial staff at jvascsurg@vascularsociety.org for additional assistance.
Table of Contents Summary and Article Highlights. Authors of Clinical and Basic Science submissions are required to include article highlights and a manuscript summary in the manuscript file (just before the abstract) using this template. Instructions are also provided below:
Table of Contents Summary: Please limit this summary to 400 characters. In the first sentence state the study design and the most important finding of this manuscript. In the second sentence state the most important conclusion.
Example 1: Intercostal artery reimplantation did not significantly decrease spinal cord injury in this retrospective study of 805 patients with open repair of TAAs and TAAAs. The authors suggest physiologic interventions to reduce the rate of spinal cord ischemia.
Example 2: This retrospective multicenter study analyzed presentation, etiology, management and outcome of 32 patients with post-EVAR aorta-enteric fistula (AEF). The study suggests that AEF is more frequent after EVAR performed for pseudoaneurysm or emergency and that treatment is associated with high mortality.
Article Highlights.The Article Highlights consist of the following three parts and are published at the beginning of clinical and basic science articles.
TYPE OF RESEARCH: Involves these components, as applicable:
1. Single or multicenter
2. Prospective, retrospective or retrospective analysis of prospectively collected registry data. *Include the abbreviated name of the registry if applicable: VQI, NSQIP, NIS, NEVSG, NSQIP-VA, etc.
3. Randomized, non-randomized Cohort, Case-control, or other (can be longitudinal or cross-sectional study or other)
*DO NOT include study topic or purpose.
Example 1. Single-center retrospective cohort study
Example 2. Retrospective review of prospectively collected Vascular Quality Initiative (VQI) data
Example 3. Multicenter retrospective cohort study
KEY FINDINGS: (Limit 300 Characters) State the most important finding(s) from the RESULTS section. Use numbers to describe exact findings (n. of pts, % of mortality, % of paraplegia, % complications, 6 months or 5-year patency, survival, etc.)
Example: Endovascular treatment of iliac artery aneurysms during EVAR using the Gore Iliac Branch Endoprosthesis (IBE) in 63 patients resulted in no mortality, in 95.1% 6 months iliac limb patency and no new onset buttock claudication.
TAKE HOME MESSAGE: State the main message established by this work.
Example: Using IBE during EVAR to preserve perfusion of the internal iliac artery is feasible with excellent patency and no buttock claudication at 6 months.
……
